PROGRAM TABLETS FOR SMALL DOGS
Riik: Austraalia
keel: inglise
Allikas: APVMA (Australian Pesticides and Veterinary Medicines Authority)
Infovoldik
(PIL)
19-06-2017
Toote omadused
(SPC)
01-07-2013
Toimeaine:
LUFENURON
Saadav alates:
ELANCO AUSTRALASIA PTY LTD
INN (Rahvusvaheline Nimetus):
lufenuron(67.8mg/Tb)
Ravimvorm:
ORAL TABLET
Koostis:
LUFENURON AMINE/AMIDE Active 67.8 mg/Tb
Ühikuid pakis:
6 Tablets
Klass:
VM - Veterinary Medicine
Valmistatud:
ELANCO AUSTRALASIA
Terapeutiline rühm:
DOG | BITCH | CASTRATE | PUPPY
Terapeutiline ala:
PARASITICIDES
Näidustused:
FLEA | FLEA ALLERGIC DERMATITIS | CTENOCEPHALIDES SPP. | GROUND FLEAS
Toote kokkuvõte:
Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG: [FLEA, FLEA ALLERGIC DERMATITIS]; For the prevention and lasting control of flea infestation and the treatment of flea allergic dermatitis in dogs weighing up to 6.7 kg.
Volitamisolek:
Registered
Loa andmise kuupäev:
2023-07-01
Infovoldik
PRODUCT NAME
:
PROGRAM TABLETS FOR SMALL DOGS:
DATE
: Wednesday, 20 October 1999
PAGE
: 1 of 5
PACK SIZES
: 6 TABLETS
TYPE OF LABEL
: Carton, Blister and Leaflet
FILE
: progsd1.doc
VERSION
: 2
REASON
: Trans-Tasman harmonisation
Text above this line is not included in the actual label.
INFOPEST VERIFIES THAT THIS LABEL IS CONSISTENT WITH THE NRA
APPROVED TEXT LABEL OF 3/8/99 ________
Carton – Front panel
FOR ANIMAL TREATMENT ONLY
PROGRAM TABLETS FOR SMALL DOGS
Active Constituent: Each tablet contains 67.8 mg LUFENURON
Contents: 6 Tablets
For the prevention and lasting control of flea infestation and as an
aid in the control of flea
allergic dermatitis in dogs weighing up to 6.7 kg
NOVARTIS Animal Health Australasia Pty Limited,
ACN 076 745 198
140-150 Bungaree Road, Pendle Hill, NSW 2145
Licensed under the Animal Remedies Act 1967 No.6451
Licensed to Novartis New Zealand Limited, 43-45 Patiki Road, Avondale,
Auckland .
PRODUCT NAME
:
PROGRAM TABLETS FOR SMALL DOGS:
DATE
: Wednesday, 20 October 1999
PAGE
: 2 of 5
PACK SIZES
: 6 TABLETS
TYPE OF LABEL
: Carton, Blister and Leaflet
FILE
: progsd1.doc
VERSION
: 2
REASON
: Trans-Tasman harmonisation
Text above this line is not included in the actual label.
Carton – Back panel
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE
ADMINISTER ONE TABLET MONTHLY FOR DOGS UP TO 6.7 KG
PROGRAM
must be given with a
FULL
meal. Either give
WITHIN
the food or
IMMEDIATELY
afterwards. It is essential that all dogs and cats in the household
(except unweaned puppies
or kittens), are treated for fleas with
PROGRAM.
For cats use
PROGRAM
suspension
(ARB No. 6452) and for dogs use
PROGRAM
tablets.
1.
BEFORE FLEAS ARE SEEN ON THE DOG.
For best results, start giving
PROGRAM
before flea activity is anticipated and
continue all year round.
2.
WHEN DOG IS ALREADY INFESTED WITH FLEAS.
PROGRAM
does not kill adult fleas. Where adult fleas are present, it will be
necessary to also treat the dog with a product registered for use
against adult fleas,
until adult flea populatio
Lugege kogu dokumenti
Toote omadused
PRODUCT NAME: PROGRAM® TABLETS FOR SMALL DOGS
PAGE: 1 OF 5
THIS REVISION ISSUED: AUGUST, 2013
SAFETY DATA SHEET
Issued by: Novartis Animal Health Australasia Pty Ltd.
Phone: 02 9805 3555 (office hours)
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
NOVARTIS ANIMAL HEALTH AUSTRALASIA PTY LTD.
ABN 64 076 745 198
TELEPHONE 02 9805 3555
(OFFICE HOURS)
54 WATERLOO RD
FAX 02 9888 8387
NORTH RYDE, NSW 2113
CHEMICAL NATURE:
Lufenuron is a benzoylurea derivative.
TRADE NAME:
PROGRAM
®
TABLETS FOR SMALL DOGS
PRODUCT USE:
For the prevention and lasting control of flea infestation and as an
aid in the control of
flea allergic dermatitis by once a month oral dose to
dogs weighing up to 6.7kg.
CREATION DATE:
AUGUST, 2013
THIS VERSION ISSUED:
AUGUST, 2013 and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
N, Dangerous to the environment.
Not classified as hazardous according to the
criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods
(ADG) Code.
RISK PHRASES:
R52. Harmful to aquatic organisms.
SAFETY PHRASES:
S25, S61. Avoid contact with eyes. Avoid release to the environment.
Refer to
special instructions/Safety Data Sheets.
SUSMP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.
HAZARD STATEMENT:
H402: Harmful to aquatic life.
PREVENTION
P102: Keep out of reach of children.
RESPONSE
P353: Rinse skin or shower with water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P332+P313: If skin irritation occurs: Get medical advice.
P337+P313: If eye irritation persists: Get medical advice.
P391: Collec
Lugege kogu dokumenti
